XM does not provide services to residents of the United States of America.
C
C

CarlZeiss

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

JPM puts Carl Zeiss on negative Catalyst Watch on downside risks to earnings

BUZZ-JPM puts Carl Zeiss on negative Catalyst Watch on downside risks to earnings ** J.P.Morgan places Carl Zeiss Meditec AFXG.DE on negative Catalyst Watch, citing downside risks to 2024 guidance and 2025 consensus ** The German medical technology firm's stock is down 2.85% ** JPM says a cut to 2024 outlook (potentially at Q3) is "well flagged" al
C
J

Anglo American, Nestle, Unilever

EUROPE RESEARCH ROUNDUP-Anglo American, Nestle, Unilever May 23 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Anglo American, Nestle and Unilever on Thursday. HIGHLIGHTS * Anglo American AAL.L : Jefferies raises target price to 3,200p from 3,000p * DCC Plc DCC.L : HSBC raises target price to 7920p from 7170p * Marks and Spencer Group MKS.L : Jefferies raises target price to 330p from 310p * Nestle SA NESN.S : JP Morgan cuts to neu
B
C
D
E
J
K
L
M
M
N
N
R
R
R
S
T
U
U
W
A
B
J
M
S

Britvic, Energean, Pandora

EUROPE RESEARCH ROUNDUP- Britvic, Energean, Pandora May 16 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Britvic, Energean and Pandora, on Thursday. HIGHLIGHTS * Britvic Plc BVIC.L : Peel Hunt raises target price to 1100p from 1000p * Energean Plc ENOG.L : Jefferies raises target price to 1,350p from 1,250p * Pandora PNDORA.CO : Citigroup raises target price to DKK 1330 from DKK 1255 * Surgical Science Sweden AB SUSW.ST : Berenbe
A
B
B
B
C
C
C
C
E
E
E
E
F
G
G
H
H
H
I
I
N
T
T
U
V
A
E
P

Mixed numbers send Carl Zeiss stock down

BUZZ-Mixed numbers send Carl Zeiss stock down ** Carl Zeiss Meditec's AFXG.DE stock falls 3.4% after the medical technology group posted "mixed" H1 numbers, according to a local trader ** The company says revenue was at 947.2 million euros ($1.02 billion) in the reporting period, below consensus according to the trader ** The trader also notes that
C

Alfen, Boliden, Pennon Group

EUROPE RESEARCH ROUNDUP-Alfen, Boliden, Pennon Group April 17 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Alfen, Boliden and Pennon Group on Wednesday. HIGHLIGHTS * Alfen ALFEN.AS : Deutsche Bank cuts to hold from buy * Boliden AB BOL.ST : JP Morgan raises to neutral from underweight * Pennon Group Plc PNN.L : RBC raises to outperform rating * Picton Property Income Ltd PCTN.L : Peel Hunt raises to buy from hold * URW URW.PA :
A
A
A
B
B
B
B
B
B
C
C
E
E
E
F
G
H
H
L
N
P
A
A
B
B
B
D

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.